Rezolute Inc (RZLT)

Healthcare | Biotechnology
Latest reporting period: 2025-09-30

Latest Quarter

2025-09-30

Revenue

$0.0

Net Income

-$18.2M

Operating Margin

N/A

Free Cash Flow

-$69.1M

Debt / Assets

7.6%

Values are in USD and rounded to the nearest whole number unless noted.

Swipe horizontally to view all columns.

Income statement quarterly history for Rezolute Inc (RZLT).
Income Statement (Quarterly) 2025-09-30 2025-03-31 2024-12-31 2024-09-30
Revenue 0 0 0 0
Cost of Revenue 0 0 0 0
Gross Profit 0 0 0 0
Operating Expenses
R&D Expenses 0 0 0 0
SG&A Expenses 6,788,000 4,740,000 4,453,000 4,187,000
Operating Expenses 19,817,000 20,023,000 17,080,000 16,941,000
Operating Income -19,817,000 0 -17,080,000 -16,941,000
Interest Expense 0 0 0 0
Income Before Tax -18,150,000 -18,914,000 -15,730,000 -15,378,000
Income Tax Expense 0 0 0 0
Net Income -18,150,000 -18,914,000 -15,730,000 -15,378,000
Per Share
EPS -0.18 -0.27 -0.22 -0.22
EPS Diluted 0.00 0.00 0.00 0.00